Previous close | 145.28 |
Open | 145.88 |
Bid | 105.90 |
Ask | 112.00 |
Strike | 1,020.00 |
Expiry date | 2025-12-19 |
Day's range | 145.28 - 148.23 |
Contract range | N/A |
Volume | |
Open interest | 40 |
Regeneron Pharmaceuticals' (NASDAQ:REGN) stock up by 4.9% over the past month. Since the market usually pay for a...
Several stocks are breaking out and trading near all-time highs.
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is the best bet in the gene therapy sector. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]